Delivery Order SPE2DB22D1017-SPE2DB24FE7BR
- Not listed
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,483.90 firm fixed-price delivery order is for the supply of 4562661923 ! CEPHALEXIN 250 MG/5 ML SUSP 200ML, a generic pharmaceutical product. The ultimate completion date for the contract is November 1, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award, valued at $4,617.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D1106|SPE2DB24FDPB7) for the supply of 4562972846 - CEPHALEXIN 250 MG/5 ML SUSP 200ML, with a completion date of December 4, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery...
- This federal contract award, valued at $30,867.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4563207552 - CEPHALEXIN 250 MG/5 ML SUSP 100ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of January 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,337.23 firm fixed price delivery order is for the supply of 4,568,682,890 units of CEPHALEXIN 250 MG/5 ML SUSP 100ML, a common antibiotic medication. The contract has an ultimate completion date of July 2, 2025. Amerisourcebergen Drug Corp is a for-profit organization based in Conshohocken, Pennsylvania and is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,680.55 firm fixed-price delivery order is for the supply of 4563895362 CEPHALEXIN 250 MG/5 ML SUSP 200ML, with a performance period ending on March 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,689.81 firm fixed-price delivery order is for the supply of 4560484281 - CEPHALEXIN 250 MG/5 ML SUSP 100ML, a generic antibiotic medication. The contract has an ultimate completion date of April 5, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564860282 CEPHALEXIN 250 MG/5 ML SUSP 200ML, a generic pharmaceutical product. The contract has a ceiling value of $28,363.81 and is a Firm Fixed Price Delivery Order with a completion date of June 11, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of CEPHALEXIN 250 MG/5 ML SUSP 100ML to the Defense Logistics Agency (DLA). The $3,355.33 Firm Fixed Price delivery order (SPE2DB20D2001|SPE2DB23FM53P) has a completion date of May 16, 2023 and was awarded on May 15, 2023. Amerisourcebergen is the prime contractor, and the contract has no set-aside designation, indicating open competition. Amerisourcebergen is a subsidiary of the...
- This federal contract award, valued at $9,471.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of CEPHALEXIN 250 MG/5 ML SUSP 200ML, a pharmaceutical product. The award is a delivery order with a firm fixed price and an ultimate completion date of January 24, 2024. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp is a major...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order worth $3,411.60 to AmerisourceBergen Drug Corp for the supply of 4560761914 - CEPHALEXIN 250 MG/5 ML SUSP 200ML. The contract has a firm fixed-price pricing type and an ultimate completion date of May 1, 2023. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not designated as a set-aside. The award is associated with a larger Indefinite Delivery Contract (IDC) between...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FE7BRDelivery Order
This federal contract award, valued at $5,862.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEPHALEXIN 250 MG/5 ML SUSP 200ML, a pharmaceutical product. The contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract is a firm fixed-price agreement with an ultimate completion date of October 12, 2023. The contract award did not utilize any set-aside designations, indicating open competition. Amerisourcebergen is the prime contractor, and its parent company is Cencora, Inc., which also does business as Amerisourcebergen. This contract supports the DLA's mission of providing essential medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 10/11/23 |